Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.
Data is available to registered users only
Buy
Sell